RA-ILD: Tracking Function and CT - Takeaways - MDSpire

RA-ILD: Tracking Function and CT

Conventional monitoring markers do not change before deaths in this predominantly mild cohort.

  • By

  • Kathryn Wighton

  • March 6, 2026

  • 4 min

Share

  • 1

    Pulmonary function and CT measures remained stable over 24 months in patients with rheumatoid arthritis-associated interstitial lung disease.

  • 2

    The study involved 105 patients, with 80% showing pulmonary fibrosis, though only 20% were classified as usual interstitial pneumonia.

  • 3

    At 24 months, 12% of patients improved, 69% remained stable, and 19% worsened, with no significant changes in quantitative CT measures.

  • 4

    Eight patients (8%) died during the study, with no preceding decline in FVC or imaging parameters noted prior to death.

  • 5

    The study's findings challenge the conventional understanding of ILD, indicating mortality can occur without prior functional decline.

Original Source(s)

RA-ILD: Tracking Function and CT

  • by Kathryn Wighton

  • March 6, 2026

Related Content

Can RAIL Predict Lupus Nephritis Course?

Urine biomarker index was associated with kidney inflammation and future treatment response across visits.

Impact of Polysaccharides from Traditional Chinese Medicine on Rheumatoid Arthritis via Gut Microbiota Alteration: A Systematic Review of Animal Studies

Obesity Not Associated With Worse Long-Term TAR Outcomes

A long-term cohort study found that obesity was not associated with worse patient-reported outcomes or higher reoperation rates following total ankle replacement in optimized surgical candidates.